Magnetic fullerenes inside single-wall carbon nanotubes

C59N magnetic fullerenes were formed inside single-wall carbon nanotubes by vacuum annealing functionalized C59N molecules encapsulated inside the tubes. A hindered, anisotropic rotation of C59N was deduced from the temperature dependence of the electron spin resonance spectra near room temperature. Shortening of spin-lattice relaxation time, T_1, of C59N indicates a reversible charge transfer toward the host nanotubes above $\sim 350$ K. Bound C59N-C60 heterodimers are formed at lower temperatures when C60 is co-encapsulated with the functionalized C59N. In the 10-300 K range, T_1 of the heterodimer shows a relaxation dominated by the conduction electrons on the nanotubes

Orientational instabilities in nematics with weak anchoring under combined action of steady flow and external fields

We study the homogeneous and the spatially periodic instabilities in a nematic liquid crystal layer subjected to steady plane {\em Couette} or {\em Poiseuille} flow. The initial director orientation is perpendicular to the flow plane. Weak anchoring at the confining plates and the influence of the external {\em electric} and/or {\em magnetic} field are taken into account. Approximate expressions for the critical shear rate are presented and compared with semi-analytical solutions in case of Couette flow and numerical solutions of the full set of nematodynamic equations for Poiseuille flow. In particular the dependence of the type of instability and the threshold on the azimuthal and the polar anchoring strength and external fields is analysed.Comment: 12 pages, 6 figure

Variable Corticosteroid Sensitivity of Thymic Cortex and Medullary Peripheral-type Lymphoid Tissue in Myasthenia Gravis Patients: Structural and Functional Effects

The thymus has been studied in myasthenia gravis patients to assess the effects of previous immunosuppresslon on total yields of cell suspension, immunohistology and culture responses. The reduction in cell yields by pretreatment with corticosteroid was very variable. In 16 of 32 cases, cortical, medullary and total cell numbers were all greatly reduced (‘depleted cases'), whereas in the others, they were within or near the typical range for untreated myasthenics. Cortical thymocytes were even more depleted than precursor thymic blasts. Thus the interpatient differences in sensitivity to corticosteroid recently described for mature T cells also affected immature cortical thymocytes and their differentiating medullary progeny.In the medulla, mature (CD3+)T lymphocytes and germinal centres were enriched by the loss of cortex and appeared relatively healthy, but somewhat depopulated. Concomitantly, in-vitro T-cell responses to acetylcholine receptor (AChR) and production of anti-A ChR antibody and total IgG by thymic cells were usually well within the typical range (assessed per 106 cells). Moreover, the total productivity of the entire thymus was reduced almost entirely by the cellular depopulation rather than by decreased function per surviving cell. Thus the main actions of this alternate day therapy with corticosteroids were apparently on total peripheral cell numbers, and perhaps on activated cells and effector mechanisms too, and its thymic effects were inessentia

Influence of Nd on the magnetic properties of Nd1-xCaxMnO3

The role played by the Nd ions in the magnetic properties of Nd0.5Ca0.5MnO3 and Nd0.7Ca0.3MnO3 is studied using static magnetization, neutron diffraction and high frequency (9.4-475GHz) Electron Spin Resonance. We show that the Nd ions are weakly coupled to the Mn ions via ferromagnetic exchange and are responsible for the peculiar ferromagnetic resonance observed in the FM phase of both compounds (ground state below 120K for x=0.3, high field state for x=0.5). We then use ESR to look for magnetic phase separation in the low field, CO phase of Nd0.5Ca0.5MnO3. We show that there is no trace of the FM phase imbedded in the CO phase, contrary to what is observed in La0.5Ca0.5MnO3 or Pr0.5Sr0.5MnO3.Comment: to be published in phys.Rev.B as a Rapid Com

Non-magnetic impurities in two dimensional superconductors

A numerical approach to disordered 2D superconductors described by BCS mean field theory is outlined. The energy gap and the superfluid density at zero temperature and the quasiparticle density of states are studied. The method involves approximate self-consistent solutions of the Bogolubov-de$\,$Gennes equations on finite square lattices. Where comparison is possible, the results of standard analytic approaches to this problem are reproduced. Detailed modeling of impurity effects is practical using this approach. The {\it range} of the impurity potential is shown to be of {\it quantitative importance} in the case of strong potential scatterers. We discuss the implications for experiments, such as the rapid suppression of superconductivity by Zn doping in Copper-Oxide superconductors.Comment: 16 pages, latex, 8 figures( available upon request

Dynamics of the Local Moment Induced by Nonmagnetic Defects in Cuprates

We present a study of the spin dynamics of magnetic defects induced by Li substitution of the plane Cu in the normal state of YBa$_2$Cu$_3$O$_{6+x}$. The fluctuations of the coupled Cu magnetic moments in the vicinity of Li are probed by near-neighbour $^{89}$Y {\it and} $^7$Li NMR spin lattice relaxation. The data indicates that the magnetic perturbation fluctuates as a single entity with a correlation time $\tau$ which scales with the local static susceptibility. This behaviour is reminiscent of the low $T$ Kondo state of magnetic impurities in conventional metals. Surprisingly it extends well above the ``Kondo'' temperature for the underdoped pseudogapped case.Comment: 4 pages, 5 figures (same), major modifications to text, accepted in PR

A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: the UK-Vanguard Study

Objective: The objective of the trial was to evaluate in a pilot setting the safety and efficacy of interleukin-2 (IL-2) therapy when used without concomitant antiretroviral therapy as a treatment for HIV infection. Design and Setting: This was a multicentre randomised three-arm trial conducted between September 1998 and March 2001 at three clinical centres in the United Kingdom. Participants: Participants were 36 antiretroviral treatment naive HIV-1-infected patients with baseline CD4 T lymphocyte counts of at least 350 cells/mm(3). Interventions: Participants were randomly assigned to receive IL-2 at 15 million international units (MIU) per day ( 12 participants) or 9 MIU/day ( 12 participants) or no treatment ( 12 participants). IL-2 was administered by twice-daily subcutaneous injections for five consecutive days every 8 wk. Outcome Measures: Primary outcome was the change from baseline CD4 T lymphocyte count at 24 wk. Safety and plasma HIV RNA levels were also monitored every 4 wk through 24 wk. The two IL-2 dose groups were combined for the primary analysis. Results: Area under curve (AUC) for change in the mean CD4 T lymphocyte count through 24 wk was 129 cells/mm(3) for those assigned IL-2 ( both dose groups combined) and 13 cells/mm(3) for control participants (95% CI for difference, 51.3 - 181.2 cells/mm(3); p = 0.0009). Compared to the control group, significant increases in CD4 cell count were observed for both IL-2 dose groups: 104.2/mm(3) ( p = 0.008) and 128.4 cells/mm(3) ( p = 0.002) for the 4.5 and 7.5 MIU dose groups, respectively. There were no significant differences between the IL-2 (0.13 log(10) copies/ ml) and control (0.09 log(10) copies/ml) groups for AUC of change in plasma HIV RNA over the 24-wk period of follow- up ( 95% CI for difference, - 0.17 to 0.26; p = 0.70). Grade 4 and dose-limiting side effects were in keeping with those previously reported for IL-2 therapy. Conclusions: In participants with HIV infection and baseline CD4 T lymphocyte counts of at least 350 cells/mm(3), intermittent subcutaneous IL-2 without concomitant antiretroviral therapy was well tolerated and produced significant increases in CD4 T lymphocyte counts and did not adversely affect plasma HIV RNA levels

The relationship between beta-2-microglobulin, CD4 lymphocyte count, AIDS and death in HIV-positive individuals

The relationship, in 539 individuals infected with the human immunodeficiency virus (HIV), between two prognostic markers, the CD4 count and beta-2-microglobulin (B2M), and the development of the acquired immunodeficiency syndrome (AIDS) and death was investigated. Cox proportional hazards models were used to determine the risk of AIDS or death. In a multivariate model which adjusted for demographic factors and treatment, the most recent measurements of B2M (relative hazard (RH) 1.37 per g/l higher) and CD4 count (RH 2.17 per log-unit lower) were both significantly associated with the development of AIDS. Similarly, in a multivariate model which additionally adjusted for the development of AIDS as a time dependant covariate, there was a strong relationship with risk of death for the most recent measurements of B2M (RH 1.34 per g/l higher), and CD4 lymphocyte count (RH 1.91 per log-unit lower). A difference in the level of B2M could be used among patients with similar CD4 counts as an indicator of increased risk of progression to AIDS or death. Using the most recent values of these markers provides a better estimate of the risk of AIDS or death, compared to the more common method of analysis, where baseline values of the markers are used

The GRA Beam-Splitter Experiments and Particle-Wave Duality of Light

Grangier, Roger and Aspect (GRA) performed a beam-splitter experiment to demonstrate the particle behaviour of light and a Mach-Zehnder interferometer experiment to demonstrate the wave behaviour of light. The distinguishing feature of these experiments is the use of a gating system to produce near ideal single photon states. With the demonstration of both wave and particle behaviour (in two mutually exclusive experiments) they claim to have demonstrated the dual particle-wave behaviour of light and hence to have confirmed Bohr's principle of complementarity. The demonstration of the wave behaviour of light is not in dispute. But we want to demonstrate, contrary to the claims of GRA, that their beam-splitter experiment does not conclusively confirm the particle behaviour of light, and hence does not confirm particle-wave duality, nor, more generally, does it confirm complementarity. Our demonstration consists of providing a detailed model based on the Causal Interpretation of Quantum Fields (CIEM), which does not involve the particle concept, of GRA's which-path experiment. We will also give a brief outline of a CIEM model for the second, interference, GRA experiment.Comment: 24 pages, 4 figure